Dashboard
Manage Tickers

DXRDAXOR CORP

Nasdaq daxor.com


$ 9.16 $ -0.33 (-3.56 %)    

Friday, 13-Sep-2024 14:09:45 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 474.86 $ 2.12 (0.45 %)
DIA $ 414.87 $ 2.97 (0.72 %)
SPY $ 561.82 $ 2.92 (0.52 %)
TLT $ 100.40 $ 0.27 (0.27 %)
GLD $ 238.66 $ 2.35 (0.99 %)
$ 9.0368
$ 9.06 x 100
-- x --
-- - --
$ 7.11 - $ 10.04
13,877
na
37.92M
$ 0.10
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-28-2012 12-31-2011 10-K
2 11-14-2011 09-30-2011 10-Q
3 08-09-2011 06-30-2011 10-Q
4 05-13-2011 03-31-2011 10-Q
5 03-29-2011 12-31-2010 10-K
6 11-12-2010 09-30-2010 10-Q
7 08-13-2010 06-30-2010 10-Q
8 05-11-2010 03-31-2010 10-Q
9 03-29-2010 12-31-2009 10-K
10 11-12-2009 09-30-2009 10-Q
11 08-13-2009 06-30-2009 10-Q
12 05-12-2009 03-31-2009 10-Q
13 03-23-2009 12-31-2008 10-K
14 11-13-2008 09-30-2008 10-Q
15 07-31-2008 06-30-2008 10-Q
16 05-15-2008 03-31-2008 10-Q
17 03-31-2008 12-31-2007 10-K
18 11-14-2007 09-30-2007 10-Q
19 08-09-2007 06-30-2007 10-Q
20 05-15-2007 03-31-2007 10-Q
21 04-02-2007 12-31-2006 10-K
22 11-15-2006 09-30-2006 10-Q
23 08-14-2006 06-30-2006 10-Q
24 05-22-2006 03-31-2006 10-Q
25 04-18-2006 12-31-2005 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

daxor-announces-review-published-in-cardiorenal-medicine-highlighting-the-role-of-blood-volume-analysis-in-enhancing-care-and-outcomes-for-cardiorenal-syndrome-bva-improves-precision-in-diuretic-and-red-cell-therapies-for-personalized-treatment
Daxor Announces Review Published In Cardio...
09/12/2024 12:02:56

ascendiant-capital-maintains-buy-on-daxor-raises-price-target-to-2475
Ascendiant Capital Maintains Buy on Daxor,...
09/09/2024 09:57:13

Ascendiant Capital analyst Edward Woo maintains Daxor (NASDAQ:DXR) with a Buy and raises the price target from $24.5 to $24.75.

daxor-receives-300k-matching-fund-award-from-launch-tennessee-to-will-drive-innovation-commercialization-efforts-and-job-creation
Daxor Receives $300K Matching Fund Award F...
09/05/2024 12:10:56

The SBIR Matching Fund Award Will Drive Our Innovation, Commercialization Efforts, and Job CreationOak Ridge, TN, Sept. 05, 202...

daxor-corporation-ceo-michael-feldschuh-delivers-mid-year-corporate-update-reports-significant-financial-growth-secures-new-government-contracts-and-announces-strategic-acquisitions-in-shareholder-letter
Daxor Corporation CEO Michael Feldschuh De...
09/03/2024 20:13:54

Dear Valued Shareholders,I am pleased to present our mid-year update for our unaudited first half results of 2024, highlighting...

daxor-corporation-shares-are-trading-higher-after-the-company-was-awarded-a-19-million-two-year-contract-from-the-us-air-force-to-develop-a-point-of-care-blood-volume-analyzer-using-novel-fluorescent-tracer-and-optical-sensing-technology
Daxor Corporation shares are trading highe...
08/06/2024 12:10:55

daxor-corporation-awarded-19m-two-year-contract-from-us-air-force-to-develop-next-generation-point-of-care-blood-volume-analyzer-using-novel-fluorescent-tracer-and-optical-sensing-technology
Daxor Corporation Awarded $1.9M Two-Year C...
08/06/2024 12:05:00

daxor-awarded-550k-us-defense-health-agency-contract-for-added-capabilities-to-its-point-of-care-blood-volume-analyzer
Daxor Awarded $550K U.S. Defense Health Ag...
07/24/2024 12:21:38

The Hematocrit Feature Will Be Integrated Into A Future Generation Blood Volume Analyzer (BVA)Oak Ridge, TN, July 24, 2024 (GLO...

daxor-corporations-bva-100-blood-volume-diagnostic-expands-to-three-new-centers-gains-traction-nationwide
Daxor Corporation's BVA-100 Blood Volume D...
07/11/2024 12:13:35

Daxor's ezBVA Lab Service Emerges as Key Driver for Expansion and Market PenetrationOak Ridge, TN, July 11, 2024 (GLOBE NEW...

daxor-corporation-to-exhibit-at-aahfn-20th-annual-meeting-showcasing-blood-volume-measurement-technology
Daxor Corporation to Exhibit at AAHFN 20th...
06/18/2024 12:18:15

daxor-corporation-acquires-volumex-and-megatope-from-its-existing-supplier-along-with-glofil-to-enhance-existing-suite-of-diagnostics-no-financial-terms-disclosed
Daxor Corporation Acquires Volumex And Meg...
03/25/2024 12:11:32

Expected to Improve Margins and Increase Revenue Streams Oak Ridge, TN, March 25, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (N...

daxor-announces-as-of-december-31-2023-daxors-net-assets-were-34010384-or-708-per-share-revenue-increased-318-year-on-year-for-2023-versus-2022-provides-corporate-update-in-letter-to-shareholders
Daxor Announces As Of December 31, 2023, D...
03/18/2024 19:09:23

Daxor Corporation (NASDAQ:DXR), the global leader in blood volume measurement technology today issued a corporate update in a L...

daxor-announces-sales-to-three-new-hospitals-furthering-expansion-of-its-user-base
Daxor Announces Sales To Three New Hospita...
03/11/2024 12:10:54

Daxor Corporation (NASDAQ:DXR), the global leader in blood volume measurement technology today announces the expansion of blood...

daxor-announces-two-significant-new-customer-transactions-with-the-cos-bva-100-in-january-no-financial-terms-disclosed
Daxor Announces Two Significant New Custom...
02/12/2024 13:15:15

Daxor Corporation (NASDAQ:DXR), the global leader in blood volume measurement technology today announces two significant new cu...

daxor-corporation-closes-q4-2023-with-growth-in-new-sales-to-hospital-systems-and-increased-utilization-of-its-bva-100-blood-volume-diagnostic-across-the-us-at-existing-accounts
Daxor Corporation Closes Q4 2023 With Grow...
02/07/2024 13:06:01

Daxor's ezBVA Lab Service Plays a Significant Role in Driving Growth and Fostering Widespread Adoption Oak Ridge, TN, Feb. ...

daxor-announces-that-the-united-states-patent-and-trademark-office-has-issued-the-company-a-second-patent-safeguarding-a-distinctive-clinical-guidance-system-for-blood-volume-management
Daxor Announces That The United States Pat...
01/09/2024 13:04:54

 This System Utilizes Unique Blood Volume Metrics And Related Clinical Measures To Create Support Guidance For Fluid Management...

daxor-announces-it-has-submitted-its-blood-volume-analyzer-daxor-bva-to-the-fda
Daxor Announces It Has Submitted Its Blood...
01/02/2024 13:33:12

The New BVA System is Designed to be Significantly Faster, Simpler and Give Results at the BedsidePotential clearance is expect...

daxor-corporation-announces-presentation-of-data-from-phase-i-nih-sponsored-trial-at-american-heart-association-annual-meeting
Daxor Corporation Announces Presentation O...
11/13/2023 13:03:15

dxr 

daxor-corporation-awarded-new-patent-for-remote-monitoring-of-blood-volume
Daxor Corporation Awarded New Patent For R...
11/09/2023 13:20:58

Patent Covers Novel Optimization of Care by Remote Monitoring Devices Including Smartwatches Oak Ridge, TN, Nov. 09, 2023 (GLOB...

daxor-corp-announces-new-data-from-banner-university-medicine-demonstrating-effectiveness-of-bva-100-use-in-ambulatory-heart-failure-patients-presented-at-heart-failure-society-of-america-annual-scientific-meeting
Daxor Corp Announces New Data From Banner ...
10/11/2023 12:04:37

Blood Volume Analysis (BVA) in 83-Patient Study Provided Highly Effective Guidance for Care of Heart Failure Patients Otherwise...

daxor-corp-wins-support-from-the-national-institutes-of-health-nih-catalyze-preclinical-services-program
Daxor Corp Wins Support from the National ...
10/04/2023 12:04:42

Daxor Corporation (NASDAQ:DXR), the global leader in blood volume measurement technology, today announces it has been accepted ...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION